GERN:NASDAQ
Geron Corp
၁.၃၁ US$
arrow_downward
-၄.၃၈%(-၀.၀၆၀) 1D
၁.၃၁ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: စက် ၁၅, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
၁.၃၇ US$
High
၁.၃၇ US$
Low
၁.၃၀ US$
Mkt. cap
၈၄.၁၆ ကုဋေ
Avg. vol.
၁.၁၁ ကုဋေ
Volume
၁.၆၅ ကုဋေ
52-wk high
၂.၀၁ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၁၀ US$
Beta
၀.၆၁
Shares outstanding
၆၄.၂၅ ကုဋေ
No. of employees
၂၅၈
Open
၁.၃၇ US$
High
၁.၃၇ US$
Low
၁.၃၀ US$
Mkt. cap
၈၄.၁၆ ကုဋေ
Avg. vol.
၁.၁၁ ကုဋေ
Volume
၁.၆၅ ကုဋေ
52-wk high
၂.၀၁ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၁၀ US$
Beta
၀.၆၁
Shares outstanding
၆၄.၂၅ ကုဋေ
No. of employees
၂၅၈
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees၂၅၈
Founded၁၉၉၀
HeadquartersMenlo Park, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitegeron.com